135 related articles for article (PubMed ID: 37014800)
1. Efficacy of vancomycin lock therapy for totally implantable venous access port-related infection due to coagulase-negative staphylococci in 100 patients with cancer.
Lafaurie M; Montlahuc C; Kerneis S; de Lastours V; Abgrall S; Manceron V; Couzigou C; Chabrol A; de Raigniac A; Lescure X; Longuet P; Lesprit P; Vanjak D; Lepeule R;
J Antimicrob Chemother; 2023 May; 78(5):1253-1258. PubMed ID: 37014800
[TBL] [Abstract][Full Text] [Related]
2. Comparing ethanol lock therapy versus vancomycin lock in a salvation strategy for totally implantable vascular access device infections due to coagulase-negative staphylococci (the ETHALOCK study): a prospective double-blind randomized clinical trial.
Lesens O; Forestier E; Botelho-Nevers E; Pavese P; David G; Nougarede B; Corbin V; Pereira B; Aumeran C; Sauvat L
Eur J Clin Microbiol Infect Dis; 2024 Feb; 43(2):223-232. PubMed ID: 37993679
[TBL] [Abstract][Full Text] [Related]
3. Outcome of totally implantable venous-access port-related infections.
Vidal M; Genillon JP; Forestier E; Trouiller S; Pereira B; Mrozek N; Aumeran C; Lesens O
Med Mal Infect; 2016 Feb; 46(1):32-8. PubMed ID: 26778362
[TBL] [Abstract][Full Text] [Related]
4. Taurolidine/Citrate Lock Therapy for Primary Prevention of Catheter-Related Infections in Cancer Patients: Results of a Prospective, Randomized, Phase IV Trial (ATAPAC).
Longo R; Llorens M; Goetz C; Platini C; Eid N; Sellies J; Ouamara N; Quétin P
Oncology; 2017; 93(2):99-105. PubMed ID: 28463827
[TBL] [Abstract][Full Text] [Related]
5. Can vancomycin lock therapy extend the retention time of infected long-term catheters?
Alonso B; Fernández-Cruz A; Díaz M; Sánchez-Carrillo C; Martín-Rabadán P; Bouza E; Muñoz P; Guembe M
APMIS; 2020 Jun; 128(6):433-439. PubMed ID: 32012332
[TBL] [Abstract][Full Text] [Related]
6. Risk factors and prognostic significance of infection of totally implantable vascular access port in solid tumor patients: A prospective cohort study.
Bailleul A; Fulgencio JP; Vimont S; Mordelet C; Ray B; Lassel L; Lapidus N; Quesnel C; Garnier M
Infect Dis Now; 2023 Oct; 53(8):104766. PubMed ID: 37543258
[TBL] [Abstract][Full Text] [Related]
7. Late complications associated with totally implantable venous access port implantation via the internal jugular vein.
Tsuruta S; Goto Y; Miyake H; Nagai H; Yoshioka Y; Yuasa N; Takamizawa J
Support Care Cancer; 2020 Jun; 28(6):2761-2768. PubMed ID: 31724073
[TBL] [Abstract][Full Text] [Related]
8. [Totally implantable venous access ports: frequency of complications and analysis of bacterial contamination after ablation].
Barbut F; Soukouna S; Lalande V; Garcia ML; Neyme D; de Gramont A; Petit JC
Pathol Biol (Paris); 2004 Dec; 52(10):566-74. PubMed ID: 15596304
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of teicoplanin versus vancomycin lock therapy in the treatment of port-related coagulase-negative staphylococci bacteraemia: a prospective case-series analysis.
Del Pozo JL; García Cenoz M; Hernáez S; Martínez A; Serrera A; Aguinaga A; Alonso M; Leiva J
Int J Antimicrob Agents; 2009 Nov; 34(5):482-5. PubMed ID: 19713086
[TBL] [Abstract][Full Text] [Related]
10. Oral minocycline as systemic therapy for uncomplicated venous access device-related bloodstream infection with coagulase-negative staphylococci after allogeneic hematopoietic cell transplantation.
Bayoudh F; Giot JB; Descy J; Fontaine C; Hayette MP; Baron F; Willems E; Beguin Y; Frippiat F; Servais S
Curr Res Transl Med; 2024 Mar; 72(1):103422. PubMed ID: 38244302
[TBL] [Abstract][Full Text] [Related]
11. Outcome of antibiotic lock technique for persistent central venous catheter-associated coagulase-negative Staphylococcus bacteremia in children.
Megged O; Shalit I; Yaniv I; Fisher S; Livni G; Levy I
Eur J Clin Microbiol Infect Dis; 2010 Feb; 29(2):157-61. PubMed ID: 19911207
[TBL] [Abstract][Full Text] [Related]
12. Comparison of methods for the microbiological diagnosis of totally implantable venous access port-related infections.
Kaya E; Tollapi L; Pastore A; Aringhieri G; Maisetta G; Barnini S; Paolicchi A; Batoni G; Esin S
J Med Microbiol; 2020 Nov; 69(11):1273-1284. PubMed ID: 33064069
[No Abstract] [Full Text] [Related]
13. Clinical outcome after a totally implantable venous access port-related infection in cancer patients: a prospective study and review of the literature.
Lebeaux D; Larroque B; Gellen-Dautremer J; Leflon-Guibout V; Dreyer C; Bialek S; Froissart A; Hentic O; Tessier C; Ruimy R; Pelletier AL; Crestani B; Fournier M; Papo T; Barry B; Zarrouk V; Fantin B
Medicine (Baltimore); 2012 Nov; 91(6):309-318. PubMed ID: 23117849
[TBL] [Abstract][Full Text] [Related]
14.
Blanco-Di Matteo A; Garcia-Fernandez N; Aguinaga Pérez A; Carmona-Torre F; Oteiza AC; Leiva J; Del Pozo JL
Antimicrob Agents Chemother; 2023 Jan; 67(1):e0126422. PubMed ID: 36602372
[TBL] [Abstract][Full Text] [Related]
15. Totally implantable venous access port infection caused by Staphylococcus pseudintermedius: Possible transmission from a companion dog to a human.
Nomoto H; Kutsuna S; Nakamura K; Nakamoto T; Shimomura A; Hirakawa T; Kinoshita N; Hayakawa K; Nagashima M; Ohmagari N
J Infect Chemother; 2020 Dec; 26(12):1305-1308. PubMed ID: 32768341
[TBL] [Abstract][Full Text] [Related]
16. Risk Factors of Infection and Role of Antibiotic Prophylaxis in Totally Implantable Venous Access Port Placement: Propensity Score Matching.
Nezami N; Xing M; Groenwald M; Silin D; Kokabi N; Latich I
Cardiovasc Intervent Radiol; 2019 Sep; 42(9):1302-1310. PubMed ID: 31187229
[TBL] [Abstract][Full Text] [Related]
17. Incidence and risk factor for infection of totally implantable venous access port.
Chang TC; Yen MH; Kiu KT
Langenbecks Arch Surg; 2022 Feb; 407(1):343-351. PubMed ID: 34550464
[TBL] [Abstract][Full Text] [Related]
18. Late complications of totally implantable venous access ports in patients with cancer: Risk factors and related nursing strategies.
Yu XY; Xu JL; Li D; Jiang ZF
Medicine (Baltimore); 2018 Sep; 97(38):e12427. PubMed ID: 30235721
[TBL] [Abstract][Full Text] [Related]
19. Short-course daptomycin lock and systemic therapy for catheter-related bloodstream infections: a retrospective cohort study in cancer patients with surgically implanted devices.
Vassallo M; Genillier PL; Dunais B; Kaphan R; Saudes L; Duval Y; Rolland F; Jullien V; Weiss N; Blanchouin E; Boscagli A; Perrin C; Montagne N
J Chemother; 2017 Aug; 29(4):232-237. PubMed ID: 28120698
[TBL] [Abstract][Full Text] [Related]
20. TIVAP-related infection due to Gram-negative aerobic bacilli: should TIVAP stay or should it go?
Rolland S; Kassis-Chikhani N; Auclin E; Bensaid S; Bidaud AL; Gerlinger MP; Blez D; Mainardi JL; Lebeaux D; Dubert M
Eur J Clin Microbiol Infect Dis; 2023 Feb; 42(2):161-168. PubMed ID: 36472717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
